An Evaluation of Cabozantinib for the Treatment of Renal Cell Carcinoma: Focus on Patient Selection and Perspectives

Autor: Iaxx R, Lefort F, Domblides C, Ravaud A, Bernhard JC, Gross-Goupil M

Publikováno v: Therapeutics and Clinical Risk Management, Vol Volume 18, Pp 619-632 (2022)

Romain Iaxx,1 Felix Lefort,1,2 Charlotte Domblides,1– 3 Alain Ravaud,1,2 Jean-Christophe Bernhard,2,4 Marine Gross-Goupil1 1Department of Medical Oncology, Hôpital Saint-André, Bordeaux University Hospital, Bordeaux, France; 2Bordeaux University,

Externí odkaz: https://doaj.org/article/97359072e0fa486ca60e79820a6207ff

Metastatic chromophobe renal cell carcinoma treated with targeted therapies: A Renal Cross Channel Group study

Autor: Colomba, E, Teuff, GL, Eisen, T, Stewart, GD, Fife, K, Larkin, J, Biondo, A, Pickering, L, Srinivasan, A, Boyle, H, Derosa, L, Sternberg, CN, Recine, F, Ralph, C, Saldana, C, Barthélémy, P, Bernhard, JC, Gurney, H, Verhoest, G, Vauleon, E, Bigot, P, Berger, J, Pfister, C, Gravis, G, Rodier, J-M, Culine, S, Caty, A, Rolland, F, Priou, F, Escudier, B, Albiges, L

$\textbf{Background}$ Treatment of non–clear cell renal cell carcinoma (RCC) remains controversial despite several recent prospective studies of targeted therapies (TT). Often Vascular Endothelial growth Factor (VEGF) and Mammalian Target of Rapamy

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::47d2b145e6356ea35188d76b22488a7f

[How radical nephrectomy compares to partial nephrectomy for the treatment of pT1a papillary renal cell carcinomas?]

Autor: Bigot, P, Bernhard, Jc, Crepel, M, Bensalah, K, Azzouzi, Ar, de la Taille, A, Salomon, L, Tostain, J, Ficarra, Vincenzo, Pantuck, Aj, Belldegrun, As, Méjean, A, Ferrière, Jm, Pfister, C, Albouy, B, Colombel, M, Zini, L, Villers, A, Montorsi, F, Shariat, S, Rioux Leclercq, N, Patard, Jj

Publikováno v: Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie. 20(5)

Our objective was to compare oncologic results of nephron sparing surgery (NSS) versus radical nephrectomy (RN) in T1aN0-x M0 papillary renal cell carcinoma (PRCC).We retrospectively reviewed 277 patients treated for a pT1aN0M0 PRCC selected from an

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::6c6d5eef7d1570ee25526c67d091bcfd
https://pubmed.ncbi.nlm.nih.gov/20471579

Nephron-sparing surgery is superior to radical nephrectomy in preserving renal function benefit even when expanding indications beyond the traditional 4-cm cutoff

Autor: Michel Soulié, Julien Drai, Jérôme Rigaud, Nicolas Mottet, Christian Pfister, Jean Marie Ferriere, Roberto Bertini, Fabien Bouliere, Olivier Bouchot, Jean-Christophe Bernhard, Thomas Bessede, Laurent Bellec, Allan J. Pantuck, Géraldine Pignot, Arie S. Belldegrun, Marc Colombel, Karim Bensalah, Laurent Salomon, Jean Jacques Patard, Pierre Bigot, Arnauld Villers, Francesco Montorsi

Publikováno v: Urologic Oncology: Seminars and Original Investigations. 32:1024-1030

Objectives To analyze to what extent partial nephrectomy (PN) is superior to radical nephrectomy (RN) in preserving renal function outcome in relation to tumor size indication. Methods and materials Clinical data from 973 patients operated at 9 acade

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::631a2b33c2efffc3403ba4369e60b0ac
https://doi.org/10.1016/j.urolonc.2014.03.012

Robot-assisted Partial Nephrectomy for Hilar and Nonhilar Renal Masses: Comparison of Perioperative, Oncological, and Functional Results in a Multicentre Prospective Cohort (NEPRAH Study, UroCCR 175).

Autor: Sarkis J; Urology Department, Grand Hôpital de l'Est Francilien, Meaux, France. Electronic address: j.sarkis@ghef.fr., Champy CM; Urology Department, Henri Mondor University Hospital, AP-HP, Creteil, France; Inserm Clinical Investigation Centre 1430, Henri Mondor University Hospital, AP-HP, Creteil, France., Doumerc N; Urology Department, CHU Rangueil, Toulouse, France., Bruyere F; Urology Department, CHRU Tours, Tours, France., Rouprêt M; Urology Department, CHU La Pitié Salpêtrière, AP-HP Paris, France., Branger N; Urology Department, Institut Paoli Calmettes, Marseille, France., Surlemont L; Urology Department, CHU Rouen, Rouen, France., Michel C; Urology Department, Hôpital Privé St. Joseph, Paris, France., Waeckel T; Urology Department, CHU Caen, Caen, France., Parier B; Urology Department, Hôpital Bicêtre, AP-HP Paris, France., Beauval JB; Urology Department, Clinique La Croix du Sud, Toulouse, France., Bigot P; Urology Department, CHU Angers, Angers, France., Lang H; Urology Department, CHRU Strasbourg, Strasbourg, France., Vallee M; Urology Department, CHU Poitiers, Poitiers, France., Guillotreau J; Urology Department, Clinique Pasteur, Toulouse, France., Patard JJ; Urology Department, CH Mont-de-Marsan, Mont-de-Marsan, France., Sarrazin C; Urology Department, CHU Grenoble, Grenoble, France., de Vergie S; Urology Department, CHU Nantes, Nantes, France., Belas O; Pôle Santé Sud, Le Mans, France., Boissier R; Aix Marseille Université, Service de Chirurgie urologique et de Transplantation rénale, CHU Conception, AP-HM, Marseille, France., Mallet R; Urology Department, Polyclinique Francheville, Périgueux, France., Panthier F; Urology Department, Hôpital Tenon, AP-HP Paris, France., Taha F; Urology Department, CHU Reims, Reims, France., Le Clerc QC; Clinique Santé Atlantique, Nantes, France., Hoquetis L; Clinique Nantes Atlantis, Saint-Herblain, France., Audenet F; Urology Department, Hôpital Européen Georges Pompidou, Paris, France., Vignot L; Urology Department, CHU Nice, Nice, France., Paparel P; Urology Department, Lyon Sud, Hospices Civils de Lyon, Lyon, France., Fontenil A; Urology Department, CHU Nîmes, Nîmes, France., Bernhard JC; Urology Department CHU Bordeaux, Bordeaux, France., Ingels A; Urology Department, Henri Mondor University Hospital, AP-HP, Creteil, France; Inserm Clinical Investigation Centre 1430, Henri Mondor University Hospital, AP-HP, Creteil, France.

Publikováno v: European urology oncology [Eur Urol Oncol] 2024 Dec; Vol. 7 (6), pp. 1487-1496. Date of Electronic Publication: 2024 Jun 26.